Novartis Pharmaceuticals brought Coyne on as the agency of record to guide the development and initial activations of its Social Media Center of Excellence (CoE). Coyne built the infrastructure of the Social Media CoE, all the while ensuring that all recommendations and programming conformed both to the highly regulated provisions of the FDA, as well as Novartis’ compliance measures.
Among the many deliverables – including counseling 13 brands across the Novartis portfolio on social media programming and initiatives – the team helped define the CoE’s mission and vision; standardized education protocols and guidance for brands and executives; spearheaded the company’s first hackathon; facilitated six unbranded and branded social influencer and ad board events; conducted ongoing social listening, analytics and insights for several brands; and helped launch the first-ever social network from a pharma manufacturer, the Together in HF Community.
